Transient leukemia of Down syndrome.


Journal

Critical reviews in clinical laboratory sciences
ISSN: 1549-781X
Titre abrégé: Crit Rev Clin Lab Sci
Pays: England
ID NLM: 8914816

Informations de publication

Date de publication:
06 2019
Historique:
pubmed: 3 5 2019
medline: 29 7 2020
entrez: 3 5 2019
Statut: ppublish

Résumé

Childhood leukemia is mostly a "developmental accident" during fetal hematopoiesis and may require multiple prenatal and postnatal "hits". The World Health Organization defines transient leukemia of Down syndrome (DS) as increased peripheral blood blasts in neonates with DS and classifies this type of leukemia as a separate entity. Although it was shown that DS predisposes children to myeloid leukemia, neither the nature of the predisposition nor the associated genetic lesions have been defined. Acute myeloid leukemia of DS is a unique disease characterized by a long pre-leukemic, myelodysplastic phase, unusual chromosomal findings and a high cure rate. In the present manuscript, we present a comprehensive review of the literature about clinical and biological findings of transient leukemia of DS (TL-DS) and link them with the genetic discoveries in the field. We address the manuscript to the pediatric generalist and especially to the next generation of pediatric hematologists.

Identifiants

pubmed: 31043105
doi: 10.1080/10408363.2019.1613629
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

247-259

Auteurs

Valentina Sas (V)

a Department of Hematology , Iuliu Hatieganu University of Medicine and Pharmacy , Cluj Napoca , Romania.
b Department of Pediatrics , Iuliu Hatieganu University of Medicine and Pharmacy , Cluj Napoca , Romania.

Cristina Blag (C)

b Department of Pediatrics , Iuliu Hatieganu University of Medicine and Pharmacy , Cluj Napoca , Romania.

Gabriela Zaharie (G)

c Department of Neonatology , Iuliu Hatieganu University of Medicine and Pharmacy , Cluj Napoca , Romania.

Emil Puscas (E)

d Department of Surgery , Iuliu Hatieganu University of Medicine and Pharmacy , Cluj Napoca , Romania.

Cosmin Lisencu (C)

d Department of Surgery , Iuliu Hatieganu University of Medicine and Pharmacy , Cluj Napoca , Romania.

Nicolae Andronic-Gorcea (N)

a Department of Hematology , Iuliu Hatieganu University of Medicine and Pharmacy , Cluj Napoca , Romania.

Sergiu Pasca (S)

a Department of Hematology , Iuliu Hatieganu University of Medicine and Pharmacy , Cluj Napoca , Romania.

Bobe Petrushev (B)

a Department of Hematology , Iuliu Hatieganu University of Medicine and Pharmacy , Cluj Napoca , Romania.

Irina Chis (I)

e Department of Physiology , Iuliu Hatieganu University of Medicine and Pharmacy , Cluj Napoca , Romania.

Mirela Marian (M)

f Department of Hematology , Ion Chiricuta Clinical Cancer Center , Cluj Napoca , Romania.

Delia Dima (D)

f Department of Hematology , Ion Chiricuta Clinical Cancer Center , Cluj Napoca , Romania.

Patric Teodorescu (P)

a Department of Hematology , Iuliu Hatieganu University of Medicine and Pharmacy , Cluj Napoca , Romania.

Sabina Iluta (S)

a Department of Hematology , Iuliu Hatieganu University of Medicine and Pharmacy , Cluj Napoca , Romania.

Mihnea Zdrenghea (M)

f Department of Hematology , Ion Chiricuta Clinical Cancer Center , Cluj Napoca , Romania.

Ioana Berindan-Neagoe (I)

g MedFuture Research Center for Advanced Medicine , Iuliu Hatieganu University of Medicine and Pharmacy , Cluj Napoca , Romania.

Gheorghe Popa (G)

b Department of Pediatrics , Iuliu Hatieganu University of Medicine and Pharmacy , Cluj Napoca , Romania.

Sorin Man (S)

b Department of Pediatrics , Iuliu Hatieganu University of Medicine and Pharmacy , Cluj Napoca , Romania.

Anca Colita (A)

h Department of Pediatrics , Carol Davila University of Medicine and Pharmacy , Bucharest , Romania.
i Department of Pediatrics , Fundeni Clinical Institute , Bucharest , Romania.

Cristina Stefan (C)

j African Organization for Research and Training in Cancer , Cape Town , South Africa.

Seiji Kojima (S)

k Department of Pediatrics , Nagoya University Graduate School of Medicine , Nagoya , Japan.
l Center for Advanced Medicine and Clinical Research , Nagoya University Hospital , Nagoya , Japan.

Ciprian Tomuleasa (C)

a Department of Hematology , Iuliu Hatieganu University of Medicine and Pharmacy , Cluj Napoca , Romania.
f Department of Hematology , Ion Chiricuta Clinical Cancer Center , Cluj Napoca , Romania.
m Research Center for Functional Genomics and Translational Medicine , Iuliu Hatieganu University of Medicine and Pharmacy , Cluj Napoca , Romania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH